| Trileptal side effects including Stevens
| |
| | lung damage, arthritis, dry eye syndrome,
|
| Johnson Syndrome (SJS) and Toxic
| |
| | and asthma. The potentially fatal
|
| Epidermal Necrolysis (TEN) have been
| |
| | Trileptal side effect Toxic Epidermal
|
| added to the drugs warning label
| |
| | Necrolysis has also been reported as a
|
| following reports of an increased risk of
| |
| | reaction to the medication. TEN is
|
| severe skin conditions in patients.
| |
| | similar to SJS in that it is a skin
|
| Trileptal can cause allergic reactions
| |
| | disease that involves the development of
|
| including skin reactions that in certain
| |
| | a rash that can spread throughout the
|
| cases can be life-threatening. Trileptal
| |
| | body. TEN starts with non-specific
|
| was approved by the Federal Drug
| |
| | symptoms that include cough, aching,
|
| Administration (FDA) in January 2000.
| |
| | fever, and headaches. This can be
|
| Trileptal, an anticonvulsant or
| |
| | followed by the development of a rash
|
| antiepileptic drug (AED), was approved
| |
| | across the face and the torso of the body
|
| for use as an adjunctive and monotherapy
| |
| | and then continue to spread to other
|
| for the treatment of partial seizures in
| |
| | areas of the body. The rash can then lead
|
| adults with epilepsy and for the
| |
| | to blisters which can form in areas such
|
| adjunctive treatment of partial seizures
| |
| | as the eyes, mouth, and vaginal areas. In
|
| in children, ages 4-16, with epilepsy.
| |
| | addition, the mucous membranes can be
|
| The precise way that Trileptal
| |
| | affected. Toxic Epidermal Necrolysis can
|
| (oxcarbazepine) exerts its antiseizure
| |
| | also cause layers of the skin to peel
|
| effect is not fully understood.
| |
| | away in sheets. The affected skin can
|
| Pharmacological activity results from
| |
| | resemble burned skin and cause serious
|
| oxcarbazepine and its monohydroxy
| |
| | infections which can lead to death. A
|
| metabolite (MHD). Oxcarbazepine and MHD
| |
| | reaction to medication is a significant
|
| are known to block voltage-sensitive
| |
| | cause of both Stevens Johnson Syndrome
|
| sodium channels, stabilizing hyper
| |
| | and Toxic Epidermal Necrolysis. Patients
|
| excited neuronal membranes, inhibiting
| |
| | of any age can find themselves affected
|
| repetitive firing, and diminution of the
| |
| | by these skin disorders. However, they
|
| propagation of synaptic impulses. These
| |
| | are typically seen in older patients and
|
| actions are thought to prevent the spread
| |
| | people with AIDS who have a diminished
|
| of seizures. Oxcarbazepine and MHD also
| |
| | ability to fight off infections due to
|
| appear to increase calcium conductance
| |
| | having a lower immunity. Patients who are
|
| and modulate calcium channels in the
| |
| | experiencing any of the symptoms
|
| central nervous system. The FDA reports a
| |
| | associated with Trileptal side effects
|
| 3 to 10 higher rate of Stevens Johnson
| |
| | should seek medical attention
|
| Syndrome (SJS) and Toxic Epidermal
| |
| | immediately. The earlier that treatment
|
| Necrolysis (TEN) than the average
| |
| | can be initiated the better chance there
|
| incidence rates for these skin disorders.
| |
| | is for recovery.
|
| Stevens Johnson Syndrome is a severe skin
| |
| | To learn more about Trileptal side
|
| disease which is potentially
| |
| | effects please visit our website. We work
|
| life-threatening. It may cause skin
| |
| | with Trileptal attorneys representing
|
| peeling, rashes, blistering and sores on
| |
| | clients in Minnesota, Wisconsin, Iowa,
|
| mucous membranes. SJS can lead to
| |
| | Arizona, North Dakota, South Dakota and
|
| scarring of mucous membranes, blindness,
| |
| | throughout the United States.
|
